Immunology - Infographic - publication highlights for spatial analysis
Can't see this email? View it online
   
  Immunology  
  The latest immunology news from News Medical  
 

Exciting approach to treating cancer with immunocytokineExciting approach to treating cancer with immunocytokine

Immunotherapy is an exciting approach to treating cancer where the patient's immune system is directed to target and kill cancer cells. To stimulate a targeted immune response toward cancer, researchers developed a new type of fusion protein called an immunocytokine, combining antibody specificity with cytokine potency. Discover how MaxCyte® electroporation enabled high-yield transient expression of bioactive immunocytokines that showed anti-tumor activity in breast and colon cancer models in mice.

Boost your clinical development
 
 
    Infographic - publication highlights for spatial analysisInfographic - publication highlights for spatial analysis
 
NGS-based spatial analysis allows researchers to capture transcriptomic and proteomic information from cells within their native tissue environment, offering a multidimensional approach to understand gene expression and regulatory pathway mechanisms. Download the infographic to view selected exciting publications in this fast-growing area.
 
Download your infographic
 
 
   Adenovirus and mRNA COVID vaccines differ in 6-month antibody durabilityAdenovirus and mRNA COVID vaccines differ in 6-month antibody durability
 
Research compares the durability of neutralizing antibody responses among recipients of three different COVID-19 vaccines (BNT162b2, mRNA-1273, and Ad26.COV2.S) over a period of 6 months.
 
   Novel computational platform can expand the pool of cancer immunotherapy targetsNovel computational platform can expand the pool of cancer immunotherapy targets
 
Researchers at Children's Hospital of Philadelphia (CHOP) and the University of California, Los Angeles (UCLA) have developed a computational platform capable of discovering tumor antigens derived from alternative RNA splicing, expanding the pool of cancer immunotherapy targets.
 
 Both vaccine strain and adjuvant selection are critical elements for improving the breadth of protective immunity against enterovirus D68
 
Both vaccine strain and adjuvant selection are critical elements for improving the breadth of protective immunity against enterovirus D68Researchers demonstrated the production of cross-clade neutralizing antibodies in response to EV-D68.
 
 
 Insights from blood donors: Serosurveillance reveals population insights for targeted health interventions
 
Insights from blood donors: Serosurveillance reveals population insights for targeted health interventionsResearch highlights the effectiveness of serosurveillance in monitoring SARS-CoV-2 exposure within a population. It emphasizes the importance of considering demographic variations in antibody prevalence to inform targeted public health strategies.
 
 
 Unraveling the Epstein-Barr virus enigma: The puzzling role in multiple sclerosis development
 
Unraveling the Epstein-Barr virus enigma: The puzzling role in multiple sclerosis developmentEpstein-Barr virus (EBV) has a significant role in the development of multiple sclerosis (MS), with evidence linking EBV infection to increased MS risk and immune dysregulation. Understanding the mechanisms underlying this connection is crucial for advancing MS therapies and prevention strategies.
 
 
 Insight into Next-Generation Protein Therapeutics
 
Insight into Next-Generation Protein TherapeuticsNext-generation protein therapeutics have become popular amongst researchers, especially after the emergence and development of novel COVID-19 vaccines, including mRNA vaccines, that thrust this concept into the spotlight at a global scale.
 
 
 Study identifies extremely potent monoclonal antibodies that neutralized multiple sarbecoviruses
 
Study identifies extremely potent monoclonal antibodies that neutralized multiple sarbecovirusesResearchers longitudinally isolated immensely potent monoclonal antibodies from macaques vaccinated with COVID-19.
 
 
 'Lost' Immune Cells Could be Partly Blamed for Impaired Vaccine Responses During Aging
 
'Lost' Immune Cells Could be Partly Blamed for Impaired Vaccine Responses During AgingUnderstanding the ways our immune response changes as we age holds the key to designing better vaccines and boosting protection for people most at risk.
 
 

Your feedback matters!
Tell us what you think

Click the button below to complete a quick survey on your newsletter experience, or send us your feedback by replying to this email.

Submit feedback